Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-29

Clinical Trial Update: Fluticasone Nasal Spray Patient Preference Study [Phase 3]

View source ↗

Summary

Phase 3 patient-preference study of Fluticasone nasal spray in allergic rhinitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flonase (fluticasone propionate nasal spray)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED | Results posted: 2018-01-29